Moderna
MRNA
#223
Rank
$66.55 B
Marketcap
$173.25
Share price
-1.76%
Change (1 day)
8.10%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: $66.55 Billion

As of February 2023 Moderna has a market cap of $66.55 Billion. This makes Moderna the world's 223th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2023

End of year Market Cap

Year Market cap Change
2023$66.55 B-3.55%
2022$69.00 B-32.99%
2021$102.97 B149.1%
2020$41.33 B528.01%
2019$6.58 B31.11%
2018$5.02 B

End of Day market cap according to different sources

On Feb 5th, 2023 the market cap of Moderna was reported to be:

$66.55 Billion
by Nasdaq
$66.55 Billion
by CompaniesMarketCap
$66.55 Billion
by Yahoo Finance
$66.55 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$430.36 B 546.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$181.96 B 173.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$260.99 B 292.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.11 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.97 B-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
$29.25 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$28.71 B-56.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.92 B-94.11%๐Ÿ‡บ๐Ÿ‡ธ USA